Serveur d'exploration Tocilizumab - Curation (PubMed)

Index « Auteurs » - entrée « Winfried Graninger »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Wilmar M. Wiersinga < Winfried Graninger < Wissam Dahoud  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000A67 (2017) Ruediger B. Mueller [Suisse] ; Winfried Graninger [Autriche] ; Páris Sidiropoulos [États-Unis] ; Christoph Goger [Autriche] ; Johannes Von Kempis [Suisse]Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysis of the Swiss and Austrian patients from the ACT-SURE study.
001156 (2015) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör ; José Alvaro-Gracia ; Karel Pavelka ; José Andrés Román Ivorra ; Winfried Graninger ; William Bensen ; Michael T. Nurmohamed ; Andreas Krause ; Corrado Bernasconi ; Maher Aassi ; Jean SibiliaErratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
001236 (2015) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör ; José Alvaro-Gracia ; Karel Pavelka ; José Andrés Román Ivorra ; Winfried Graninger ; William Bensen ; Michael T. Nurmohamed ; Andreas Krause ; Corrado Bernasconi ; Maher Aassi ; Jean SibiliaComparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
001773 (2013) Josef S. Smolen [Autriche] ; Monika M. Schoels ; Norihiro Nishimoto ; Ferdinand C. Breedveld ; Gerd R. Burmester ; Maxime Dougados ; Paul Emery ; Gianfranco Ferraccioli ; Cem Gabay ; Allan Gibofsky ; Juan Jesus Gomez-Reino ; Graeme Jones ; Tore K. Kvien ; Miho Murakami ; Neil Betteridge ; Clifton O. Bingham ; Vivian Bykerk ; Ernest H. Choy ; Bernard Combe ; Maurizio Cutolo ; Winfried Graninger ; Angel Lanas ; Emilio Martin-Mola ; Carlomaurizio Montecucco ; Mikkel Ostergaard ; Karel Pavelka ; Andrea Rubbert-Roth ; Naveed Sattar ; Marieke Scholte-Voshaar ; Yoshiya Tanaka ; Michael Trauner ; Gabriele Valentini ; Kevin L. Winthrop ; Maarten De Wit ; Désirée Van Der HeijdeConsensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.
001861 (2012) Vivian P. Bykerk [États-Unis] ; Andrew J K. Ostör ; José Alvaro-Gracia ; Karel Pavelka ; José Andrés Román Ivorra ; Winfried Graninger ; William Bensen ; Michael T. Nurmohamed ; Andreas Krause ; Corrado Bernasconi ; Andrea Stancati ; Jean SibiliaTocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Winfried Graninger" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Winfried Graninger" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Winfried Graninger
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021